Federal Circuit Rules for Pfizer in Suit Vs. Ranbaxy
The Court of Appeals for the Federal Circuit last week upheld a preliminary injunction barring India's Ranbaxy Pharmaceuticals from marketing a generic version of Pfizer's Vantin antibiotic, Pfizer said....To view the full article, register now.
Already a subscriber? Click here to view full article